Moderna wins Nasdaq-100 inclusion, Warner Bros. Discovery out

Moderna (MRNA) will join the Nasdaq-100 index on 9 October 2026, replacing Warner Bros. Discovery (WBD) due to its pending acquisition. Moderna's shares rose 42.12% in 20 trading days, driven by positive trial data for a melanoma vaccine, despite reporting net losses. WBD's exit is due to its merger with Paramount Skydance, not underperformance.

Original reporting
Published Oct 2, 2026, 8:08 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 2, 2026, 1:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Moderna wins Nasdaq-100 inclusion, Warner Bros. Discovery out — source image
Decision brief

The 30-second read

$MRNABullishHigh
01

Why it matters

The inclusion/exclusion will cause mechanical buying/selling by passive funds, potentially amplifying price moves beyond fundamentals.

02

Market read

Index rebalancing creates short‑term trading opportunities for both stocks as funds adjust holdings.

03

What to watch

Fund managers may weigh the company's loss streak and trial risk against index‑driven buying.

Relevance 7/10Novelty 8/10Timing: pre‑market on 9 Oct 2026

Background

Nasdaq-100 composition changes are periodic and driven by market cap and liquidity; this move reflects Moderna's recent price surge and WBD's pending merger.

Company-level read

Ticker impact

$MRNABullishHigh confidence
Context

Moderna is added to the Nasdaq-100 effective 9 Oct, triggering passive fund buying and supporting its recent 42% rally.

Expected impact

upward as passive funds buy on inclusion

Evidence & confidence

Nasdaq-100 inclusion forces fund rebalancing, historically boosting added stocks.

$WBDBearishHigh confidence
Context

Warner Bros. Discovery is removed from the Nasdaq-100 ahead of its pending Paramount Skydance acquisition, prompting fund outflows.

Expected impact

downward as passive funds sell on removal

Evidence & confidence

Removal from a major index forces tracking funds to liquidate positions.

Market effects

Highlights the weight of biotech in the Nasdaq-100 and may shift sector allocations.

U.S. equity indices adjust as two large‑cap constituents change.

Index rebalancing can affect global fund flows and ETFs tracking the Nasdaq-100.

Counterpoint

Despite the inclusion, Moderna's ongoing losses suggest caution; the rally may be speculative.

Key entities

  • Moderna

    Biotech firm added to Nasdaq-100

  • Warner Bros. Discovery

    Media company removed from Nasdaq-100

Related articles

$MRNAHighAI 8/10

Moderna (MRNA) Surges 37% in September Despite Healthcare Sector

Moderna (MRNA) surged 37.22% in September due to promising Phase 3 results for its personalized mRNA cancer vaccine, outperforming the broader healthcare sector. The company's P/S ratio is 33.44, significantly higher than its historical median of 8.41, reflecting high growth expectations. Moderna remains unprofitable, with a GF Score of 54/100, indicating mixed financial health. Insider activity shows significant selling, while guru ownership is mixed.

$WBDHighAI 9/10

Paramount and Warner Bros. Set to Merge Under Skydance Name

Paramount Skydance will acquire Warner Bros. Discovery on October 6, operating under the Skydance name. The merger combines major entertainment brands and streaming platforms, including HBO Max and Paramount+. CEO David Ellison plans to merge the two streaming services, potentially reaching 200 million subscribers. Details on the combined service's name and pricing remain undisclosed.

$WBDHighAI 9/10

Skydance Blasts Off: Can David Ellison Make Paramount-Warner Bros. Merger Fly?

David Ellison's Skydance Corp. is set to complete an $111 billion merger with Warner Bros. Discovery, creating a major entertainment powerhouse. The deal, closing on Oct. 6, faced regulatory and legal hurdles but was approved after a settlement with state attorneys general. Ellison and co-CEO Ynon Kreiz will lead the combined company, focusing on debt reduction and profit growth across film, TV, and streaming. The merged entity will list on the NYSE under the ticker 'SKYD'.

$WBDHighAI 9/10

Paramount and Warner Bros. Discovery merger to create Skydance

Paramount and Warner Bros. Discovery plan to merge, creating a new company called Skydance, valued at $110 billion, expected to close October 6. The deal combines major studios, networks, and franchises. David Ellison, Paramount CEO, cited distinct identities and legacies. The merger faces a lawsuit from 12 states but recently cleared a legal hurdle. Ynon Kreiz, former Mattel CEO, will be co-CEO of the combined entity.

$WBDMed

Paramount And Warner Bros. Combined Company To Operate As Skydance

David Ellison announced the combined entity of Paramount and Warner Bros. will operate as Skydance, preserving individual studio brands. The new structure aims to enhance creative output and global growth while maintaining distinct identities. Skydance will focus on storytelling and leveraging scale for expansion.